Brian Walitt: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(→‎Learn more: Add article)
(→‎Notable studies: Add study)
Line 12: Line 12:
==Notable studies==
==Notable studies==
*[[NIH Post-Infectious ME/CFS Study]]
*[[NIH Post-Infectious ME/CFS Study]]
*2015, [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750385/ Chemobrain: A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy]


==Talks & interviews==
==Talks & interviews==

Revision as of 13:22, February 21, 2016

Doctor Brian Walitt is a pain researcher at the National Institutes of Health (NIH) in the United States and oversees intramural clinical protocols. He is the lead clinical investigator of the NIH Post-Infectious ME/CFS Study.

Research[edit | edit source]

Dr. Walitt's self-stated research interests include "Pain and related interoceptive disorders (i.e. fibromyalgia, chronic fatigue)" and "Social construction of illness and disease."

Controversy[edit | edit source]

Walitt believes that fibromyalgia is a "psychosomatic experience," a variant of normal, and not an abnormal disease state that should be medicalized.[1] He has stated that fibromyalgia is not a disease but rather a way of "dealing with the difficulties of just being a human.”[2]

In a 2015 paper on chemotherapy related cognitive dysfunction[3] co-authored by Walitt, fibromyalgia and chronic fatigue syndrome are referred to as somatoform illnesses, with their hallmark being a "...discordance between the severity of subjective experience and that of objective impairment...".

Notable studies[edit | edit source]

Talks & interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]